EUVIMEDEUVIMED entdecken
Crossref

Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β‐catenin axis

Munmun Panda, Stuti Biswal, Bijesh K Biswal iD

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09477-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Munmun Panda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology, Rourkela, Odisha,, 769008, India. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Quinazolines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: University Grant Commission (UGC), New Delhi, India, Department of Science and Technology, Science and Engineering Research Board (DST, SERB), New Delhi, India, Department of Science and Technology, Odisha, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsQuinazolinesHumansCisplatinbeta CateninEpithelial-Mesenchymal TransitionReactive Oxygen SpeciesCell DeathSOX9 Transcription Factor

Stichwörter der Autor:innen

β-cateninCisplatin resistanceEvodiamineNon-small-cell lung cancerSOX9

Substanzen

evodiamineCisplatinbeta CateninReactive Oxygen SpeciesSOX9 protein, humanSOX9 Transcription FactorQuinazolines

Autor:innen und Institutionen

  • Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology, Rourkela, Odisha,, 769008, India.
  • Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology, Rourkela, Odisha,, 769008, India. biswalb@nitrkl.ac.in.

ORCID-Profile: Bijesh K Biswal

Förderung

  • University Grant Commission (UGC), New Delhi, India
  • Department of Science and Technology, Science and Engineering Research Board (DST, SERB), New Delhi, India
  • Department of Science and Technology, Odisha, India

Zitieren

APA

Panda, M., Biswal, S., & Biswal, B. K. (2024). Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β‐catenin axis. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09477-7

Vancouver

Panda M, Biswal S, Biswal BK. Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β‐catenin axis. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09477-7

BibTeX
@article{Panda2024,
  author = {Panda, Munmun and Biswal, Stuti and Biswal, Bijesh K},
  title = {Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β‐catenin axis},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09477-7}
}
Kostenlos starten →